Related Experiment Video
Updated: Mar 6, 2026

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Diminished liver microperfusion in Fontan patients: A biexponential DWI study
Hildebrand Dijkstra1, Djoeke Wolff2, Joost P van Melle3
1Center for Medical Imaging-North East Netherlands, Department of Radiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Abstract:
It has been demonstrated that hepatic apparent diffusion coefficients (ADC) are decreasing in patients with a Fontan circulation. It remains however unclear whether this is a true decrease of molecular diffusion, or rather reflects decreased microperfusion due to decreased portal blood flow. The purpose of this study was therefore to differentiate diffusion and microperfusion using intravoxel incoherent motion (IVIM) modeled diffusion-weighted imaging (DWI) for different liver segments in patients with a Fontan circulation, compare to a control group, and relate with liver function, chronic hepatic congestion and hepatic disease. For that purpose, livers of 59 consecutively included patients with Fontan circulation (29 men; mean-age, 19.1 years) were examined (Oct 2012─Dec 2013) with 1.5T MRI and DWI (b = 0,50,100,250,500,750,1500,1750 s/mm2). IVIM (Dslow, Dfast, ffast) and ADC were calculated for eight liver segments, compared to a control group (19 volunteers; 10 men; mean-age, 32.9 years), and correlated to follow-up duration, clinical variables, and laboratory measurements associated with liver function. The results demonstrated that microperfusion was reduced (p<0.001) in Fontan livers compared to controls with ─38.1% for Dfast and ─32.6% for ffast. Molecular diffusion (Dslow) was similar between patients and controls, while ADC was significantly lower (─14.3%) in patients (p<0.001). ADC decreased significantly with follow-up duration after Fontan operation (r = ─0.657). Dslow showed significant inverse correlations (r = ─0.591) with follow-up duration whereas Dfast and ffast did not. From these results it was concluded that the decreasing ADC values in Fontan livers compared with controls reflect decreases in hepatic microperfusion rather than any change in molecular diffusion. However, with the time elapsed since the Fontan operation molecular diffusion and ADC decreased while microperfusion remained stable. This indicates that after Fontan operation initial blood flow effects on the liver are followed by intracellular changes preceding the formation of fibrosis and cirrhosis.
Insights
Decreased liver apparent diffusion coefficients (ADC) in Fontan circulation patients are due to reduced microperfusion, not molecular diffusion changes. Over time, molecular diffusion also decreases, indicating early intracellular changes before fibrosis.
Area of Science:
- Radiology
- Hepatology
- Cardiology
Background:
- Hepatic apparent diffusion coefficients (ADC) decrease in Fontan circulation patients, but the cause (diffusion vs. microperfusion) is unclear.
- Understanding this distinction is crucial for managing potential liver disease in these patients.
Purpose of the Study:
- To differentiate between true molecular diffusion and microperfusion in Fontan circulation livers using intravoxel incoherent motion (IVIM) modeling.
- To compare these parameters with a control group and correlate them with liver function and disease progression.
Main Methods:
- 1.5T MRI with diffusion-weighted imaging (DWI) was used to examine 59 Fontan patients and 19 controls.
- IVIM parameters (Dslow, Dfast, ffast) and ADC were calculated for liver segments.
- Correlations were made with clinical data, follow-up duration, and liver function tests.
Main Results:
- Fontan livers showed significantly reduced microperfusion (Dfast, ffast) compared to controls.
- Molecular diffusion (Dslow) was similar, but ADC was lower in Fontan patients.
- ADC and Dslow decreased with longer follow-up duration post-Fontan, while microperfusion remained stable.
Conclusions:
- Decreasing ADC in Fontan livers primarily reflects reduced hepatic microperfusion, not altered molecular diffusion.
- Long-term, both molecular diffusion and ADC decline post-Fontan, suggesting early intracellular changes preceding fibrosis and cirrhosis.
More Related Videos
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

